Today’s essay is a little personal for me. The opportunity I’m about to tell you about stems from a condition I suffer from, along with millions of other Americans. But as I’ll explain in a moment, there are several companies quietly working on game-changing treatments that could not only offer relief — but also a windfall of profits to investors. If you don’t take care of yourself, they keep telling me, you can’t take care of anyone else. #-ad_banner-#And lately, I’ve been thinking about my own personal medical condition, diabetes mellitus, also commonly referred to as “Type I,” “insulin-dependent” or… Read More
Today’s essay is a little personal for me. The opportunity I’m about to tell you about stems from a condition I suffer from, along with millions of other Americans. But as I’ll explain in a moment, there are several companies quietly working on game-changing treatments that could not only offer relief — but also a windfall of profits to investors. If you don’t take care of yourself, they keep telling me, you can’t take care of anyone else. #-ad_banner-#And lately, I’ve been thinking about my own personal medical condition, diabetes mellitus, also commonly referred to as “Type I,” “insulin-dependent” or “juvenile-onset” diabetes. Diabetes is a metabolic disorder characterized by a malfunctioning pancreas. All food turns into sugar through digestion, but diabetics are unable to absorb the sugar the body needs to feed itself. Insulin, a hormone secreted by the pancreas’ beta cells, helps usher glucose through the cell’s semi-permeable membrane. Without insulin, sugar builds up in the bloodstream, causing a condition called hyperglycemia. Too much insulin (or not enough sugar) and the blood sugar goes too low, which is known as hypoglycemia. Type I diabetics must carefully monitor their carbohydrate intake and inject insulin to keep their blood sugar in… Read More